Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.

Combined probiotic formulation of no benefit to children with gastroenteritis

01 Jan 2019

Twice-daily administration of a combined Lactobacillus rhamnosus and Lactobacillus helveticus probiotic in children with gastroenteritis fails to prevent the development of moderate-to-severe gastroenteritis within 2 weeks after presentation, as shown in a recent study.

Researchers randomized 886 babies with gastroenteritis aged 3–48 months to receive a 5-day course of a combination probiotic product containing L. rhamnosus R0011 and L. helveticus R0052 at a dose of 4.0×109 colony-forming units twice daily (n=444) or placebo (n=442), among whom 414 and 413, respectively, completed follow-up.

The primary outcome of incident moderate-to-severe gastroenteritis – defined according to a postenrolment modified Vesikari scale symptom score of 9 – within 14 days after enrolment was similar in the probiotics and placebo groups (26.1 percent vs 24.7 percent, respectively; odds ratio [OR], 1.06; 95 percent CI, 0.77–1.46; p=0.72).

Multivariable logistic regression analysis showed no significant association between treatment and the risk of developing moderate-to-severe gastroenteritis (OR, 1.06; 0.76–1.49; p=0.74).

Furthermore, there were no significant differences seen between the probiotic and placebo groups in terms of the median duration of diarrhoea (52.5 vs 55.5 hours; p=0.31) or vomiting (17.7 vs 18.7 hours; p=0.18), the percentage of children with unscheduled visits to a health care provider (30.2 percent vs 26.6 percent; OR, 1.19; 0.87–1.62; p=0.27), and the percentage of those who had an adverse event (34.8 percent vs 38.7 percent; OR, 0.83; 0.62–1.11; p=0.21).

The present data suggest that the combined probiotic formulation is not effective in preventing moderate-to-severe gastroenteritis within 14 days in infants and young children presenting with symptoms of gastroenteritis for up to 72 hours and have been brought for care in the emergency department, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.